The use of furosemide during Intravenous Immunoglobulin therapy should not always be considered contraindicated

The use of furosemide during Intravenous Immunoglobulin therapy should not always be considered contraindicated

Aims: Endothelial damage in acute respiratory distress syndrome (ARDS) increases capillary permeability, resulting in an increase in free lung fluid, interstitial pulmonary edema, and ventilation-perfusion imbalance. Due to their high osmolarity, Intravenous Immunoglobulin (IVIG) treatment may deepe...

Full description

Bibliographic Details
Main Authors: Serdar EFE, Fatih Demircan, Anıl UÇAN, Volkan İNAL
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Medicine in Drug Discovery
Subjects:
Convalescent plasma
COVID ARDS
Furosemid
HFNC
IvIg
Online Access:http://www.sciencedirect.com/science/article/pii/S2590098623000210

Internet

http://www.sciencedirect.com/science/article/pii/S2590098623000210

Similar Items